Summary of safety profile: The majority of undesirable effects are the consequence of the vasodilator effects of nicardipine. The most common effects are headache, dizziness, peripheral oedema, palpitations and flushing.
Tabulated list of adverse reactions: Adverse reactions listed as follows have been observed during clinical studies and/or after marketed use and are based on clinical trial data and classified according to MedDRA System Organ Class. Frequency categories are defined according to the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000) and not known (cannot be estimated from the available data). (See table.)
Click on icon to see table/diagram/image